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Abstract
Background: We introduce Glaucoma Discovery Platform (GDP), an online environment for facile visualization and
interrogation of complex transcription profiling datasets for glaucoma. We also report the availability of Datgan, the
suite of scripts that was developed to construct GDP. This reusable software system complements existing
repositories such as NCBI GEO or EBI ArrayExpress as it allows the construction of searchable databases to
maximize understanding of user-selected transcription profiling datasets.
Description: Datgan scripts were used to construct both the underlying data tables and the web interface that
form GDP. GDP is populated using data from a mouse model of glaucoma. The data was generated using the
DBA/2J strain, a widely used mouse model of glaucoma. The DBA/2J-Gpnmb
+ strain provided a genetically
matched control strain that does not develop glaucoma. We separately assessed both the retina and the optic
nerve head, important tissues in glaucoma. We used hierarchical clustering to identify early molecular stages of
glaucoma that could not be identified using morphological assessment of disease. GDP has two components. First,
an interactive search and retrieve component provides the ability to assess gene(s) of interest in all identified
stages of disease in both the retina and optic nerve head. The output is returned in graphical and tabular format
with statistically significant differences highlighted for easy visual analysis. Second, a bulk download component
allows lists of differentially expressed genes to be retrieved as a series of files compatible with Excel. To facilitate
access to additional information available for genes of interest, GDP is linked to selected external resources
including Mouse Genome Informatics and Online Medelian Inheritance in Man (OMIM).
Conclusion: Datgan-constructed databases allow user-friendly access to datasets that involve temporally ordered
stages of disease or developmental stages. Datgan and GDP are available from http://glaucomadb.jax.org/
glaucoma.
Background
Transcription profiling is a powerful tool for under-
standing biological process and the role they play in the
pathogenesis of disease. For complex diseases, it is
necessary to assess many different samples, resulting in
very large amounts of data that are cumbersome to ana-
lyze and understand. Specific analyses often require sig-
nificant computing power, time and analytical expertise.
These needs hinder detailed interrogation of deposited
datasets by many members of the scientific community.
Transcription profiling datasets are deposited in central
databases such as Gene Expression Omnibus (GEO) at
the National Center for Biotechnology Information
(NCBI) [1] and ArrayExpress at the European Bioinfor-
matics Institute (EBI) [2]. GEO and ArrayExpress are
designed to efficiently store large data sets and to pro-
vide mechanisms that allow the scientific community to
query, locate, review and download experiments of
interest. Although useful, we have found that these plat-
forms are not ideal for optimal interrogation of large
and complex datasets. We became aware of the need for
a more optimized and facile environment for analyzing
complex datasets when studying glaucoma, a complex
and asynchronous neurodegenerative disease. Our data-
sets consists of multiple, temporally ordered stages of
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searching and retrieving of differentially expressed genes
in multiple stages of disease compared to a no-disease
control.
To meet this need, we developed Glaucoma Discovery
Platform (GDP), an online environment to visualize and
interrogate large and complex expression datasets in a
user-friendly manner. GDP allows simultaneous query-
ing of multiple genes, viewing results across multiple
datasets and assessing expression differences for multi-
ple probe sets for each gene. To our knowledge, no
other resource is available that provides this combina-
tion of user-friendly functionality provided by GDP. We
deployed GDP to derive maximum benefit from an
extensive transcription profiling study of glaucoma. The
study focused on identifying early molecular stages that
occur prior to significant damage (described in more
detail below and [3]). More than 100 different samples
from at least 50 mice were profiled and 70 pairwise
group comparisons were made. GDP utilizes a web-
based user interface to access the underlying gene
expression profiling data, which is organized on a
MySQL database server. GDP has greatly facilitated our
understanding of these glaucoma data. Its user-friendly
interface provides easy and instant data interrogation
without a need for specialized knowledge or training. It
thereby allows general access to our glaucoma datasets
and is freely available for the benefit of the wider scien-
tific community.
We also report the availability of Datgan (Welsh,
meaning ‘to express’), the suite of scripts that was used
to construct both the underlying data tables and the
web interface that form GDP. Datgan was written in
the python language. It is packaged as a reusable soft-
ware system for constructing and populating discovery
platforms to visualize user-determined sets of tran-
scription profiling data. Datgan is organized to allow
biologists with some experience running scripts (or a
systems administrator) to establish their own persona-
lized discovery platforms and can be readily adapted to
incorporate transcription profiling data generated
using RNA-seq.
Construction and content
Populating GDP with profiling data for glaucoma
Glaucoma is a complex, neurodegenerative disorder
affecting 70 million people worldwide and is associated
with the death of retinal ganglion cells (RGCs) and the
associated degeneration of the optic nerve [4]. DBA/2J
is a widely used mouse model of glaucoma that shows
hallmarks of human glaucoma including age-related IOP
elevation, optic nerve excavation and regional patterns
of RGC loss [5-10]. DBA/2J mice develop glaucoma as a
result of a disease of the iris that leads to an elevation
in IOP. The disease of the iris is caused by mutations in
two genes, Gpnmb
R150X and Tyrp1
b[5,6]. DBA/2J-
Gpnmb
+ mice have a functioning Gpnmb gene and
serve as a genetically matched control strain that does
not develop glaucoma [11]. An important insult occurs
to RGC axons at the optic nerve head in DBA/2J glau-
coma [7]. However, other compartments of the RGC
also are likely to undergo early changes in glaucoma
such as the RGC soma [12] and synapses [13]. The
mechanisms involved in these early changes are not well
understood.
The gene expression profiling study that is included in
GDP, investigated early changes in both the optic nerve
head and retina for individual eyes from DBA/2J mice
(described in detail elsewhere, [3]). Briefly, the optic
nerve head and retina for each eye were separately pro-
filed using Mouse 430 v2 arrays (Affymetrix). 50 DBA/
2J eyes and 10 DBA/2J-Gpnmb
+ control eyes were stu-
died. All data were processed and analyzed using MAA-
NOVA [14]. DBA/2J eyes were initially grouped based
on conventional morphological criteria including degree
of optic nerve damage (dataset 1: four groups, Figure
1A). However, comparisons of these groups were not
sensitive at identifying disease changes that precede
morphological damage. Therefore, hierarchical cluster-
ing, a method widely used in cancer biology, [7,11,15]
was used to group eyes undergoing early stages of dis-
ease and allowed much more sensitive detection of early
disease changes. Eyes were clustered into different stages
using both the expression profiles for the optic nerve
head (dataset 2: five stages, Figure 1B) and the retina
(dataset 3: four stages, Figure 1C). To identify differen-
tially expressed genes for all three datasets, all possible
pairwise comparisons were performed. In total, more
than 70 different pairwise comparisons were made and
many thousands of differentially expressed genes identi-
fied. All raw data has been deposited in NCBI GEO
(Accession number: GSE26299).
Building GDP using Datgan scripts
GDP is constructed as a series of interconnected data
tables (Figure 2). Data was loaded in four phases using
the first major component of Datgan: First, raw normal-
ized expression values (generated using R/Maanova)
were loaded for each probe set for each sample. Second,
analyzed data was loaded, including relative fold change
and q value, from all pairwise comparisons for all 3
datasets (Morphological, Molecular ONH and Molecular
retina). Third, using a previously constructed design file,
relationships between the raw data for each sample and
the sample groups were established. Finally, gene anno-
tations to the probe sets were loaded from the Mouse
Genome Database [16] using public reports available
from the Mouse Genome Informatics (MGI) ftp site
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Page 2 of 13Figure 1 Datasets available in the first release of GDP. Each of the three datasets follows a progression through glaucoma. Both optic nerve
head and retinal expression data are represented within each dataset [3]. (a) Morphological dataset. Glaucoma developing DBA/2J samples
(white boxes) and strain-matched D2-Gpnmb
+ no glaucoma control samples (grey box). Stages of glaucoma were determined morphologically
by assessing optic nerve damage just behind the orbit (see Methods and [11,15,34]). (b) Molecular ONH dataset. Hierarchical clustering using the
expression levels of a set of glaucoma specific genes grouped the optic nerve heads into 5 molecularly defined stages. Stages 1, 2 and 3
represent early states of glaucoma, which precede morphologically detectable glaucoma and so were not previously distinguishable using
conventional analyses. Stages 4 and 5 contain eyes with moderate and severe optic nerve damage respectively. (c) Molecular retina dataset. A
similar hierarchical clustering was performed using the retinal expression data. Four stages of disease were identified with stages R1 and R2 not
previously detectable using morphological analysis. Stages R3 and R4 contain eyes with moderate and severe optic nerve damage respectively.
Optic nerve heads and retinas were assessed from the same set of eyes.
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Page 3 of 13Figure 2 Schematic of database architecture. The diagram describes the database schema behind GDP. For convenience, it is organized into
four major areas (color coded), (A) Datasets, samples and raw data (green), (B) statistics and annotations (orange), (C) convenience or lookup
tables (red) and (D) data imported from MGI (green). Tables are populated in four steps. First, raw normalized intensity values (table name: raw
data), samples and probes are added. Second, the analyzed data (statistics, comparisons) and groupings (describing the datasets such as
molecular ONH and tissue ONH) are loaded. Third, a previously generated design file allows the associations between samples and groups to be
established (sampletogroups). Finally, MGI annotations (all symbols, synonyms, markers, human_orthologs and probeset_to_mgid) are loaded
and the convenience look up tables (probecounts, representativeprobes and ave_qvalue) established. Within each table, required columns are
indicated. VARCHAR indicates a string is required, and the number in brackets indicates the number of characters allowed in that string. Lines
indicated connections between tables.
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not only to search by gene symbols, but also by their
synonyms/aliases.
The web interface is implemented using the Ruby on
Rails web application framework http://rubyonrails.org
in combination with the second major component of
Datgan, a series of custom and public Javascript
libraries. The interface leverages AJAX technology
(asynchronous JavaScript and XML) to allow dynamic
regeneration of plots in the same page view, while main-
taining the main query panel. The database application
infrastructure was implemented in a generic manner,
allowing for its reuse for other profiling datasets, and to
make it easier to load additional experimental results
into GDP. The web-based interactive search and retrieve
component provides the ability to assess multiple gene
(s) of interest in temporally and/or spatially defined
developmental or disease stages. The output is returned
in graphical and tabular format with statistically signifi-
cant differences highlighted for easy visual analysis. Data
for all probe sets for a given gene can be accessed as
well as all data for individual samples within groups.
Additionally, a bulk download component allows lists of
differentially expressed genes to be retrieved as a series
of tab delimited files. To facilitate access to additional
functional information for a given gene, links are pro-
vided to external resources.
Visualizing and interrogating profiling data with GDP
The web-based interface is divided into 4 main sections;
(a) homepage/new search, (b) results, (c) probe set
details and (d) expression values (Figure 3). A number
of links are provided to selected external resources such
as Mouse Genome Informatics [17], EntrezGene and the
Online Medelian Inheritance in Man (OMIM) databases
[18] and Kyoto Encyclopedia of Genes and Genomes
(KEGG) [19] that allows users to access genetic, pheno-
typic and functional information for genes of interest
(see External links below). The platform is also well sup-
ported by help pages.
Home page/new search (Figure 3a)
T h eh o m ep a g ep r o v i d e sa no v e r v i e wo ft h ed a t a b a s e
and permanent headers for convenient links to the bulk
download page and the detailed users quick guide. The
bulk downloads page allows all differentially expressed
genes and associated information for individual compar-
isons to be downloaded in excel-friendly format. The
quick search feature allows a single gene to be searched
in all datasets. Information on downloading Datgan is
also provided.
There are a variety of different ways to interrogate the
data using the detailed search tool. Firstly, if a user has
a set of genes that they are interested in assessing, the
official gene symbols (or MGI-recognized aliases) can be
entered or pasted into the appropriate text box (Figure
4). Alternatively, there is a wild card (*) capability
where, for instance, the results for all members of the
tumor necrosis (Tnf) superfamily can be retrieved by
searching for “Tnf*” (described in detail below and Fig-
ure 4). By default, datasets and tissues “Molecular ONH:
tissue ONH” and “Molecular retina: tissue retina” are
selected as these are the most sensitive at identifying
differentially expressed genes in the optic nerve head
and retina respectively. However, the user is also able to
select the dataset(s) of interest (see Figure 1), the tissue
(s) of interest (optic nerve head or retina) and the refer-
ence group (e.g. the D2-Gpnmb
+ control group). Includ-
ing additional datasets and tissues does slow the search
time. It is possible to restrict the results by fold change
and/or significance value (q value). The user can select
whether the results are ordered by significance (lowest
average q value across all groups) or by gene symbol
(alphanumeric). The q value is a measure of the false
detection rate and gives an indication of the significance
of the fold change. It is a standard statistic for microar-
ray analyses [20]. The lower the q value, the more sig-
nificant a fold change is considered to be. In our study,
genes are considered differentially expressed, with
respect to the reference, if the q value is less than 0.05
(roughly equivalent to a false detection rate of 5%).
Finally, fold changes can be reported as either relative
fold change (compared to reference), or as log2 fold
change (compared to reference).
The results summary page (Figure 3b)
Results are returned in both graphical and tabular for-
mat. Any gene names that were not recognized from
the search page are listed and links to MGI are given
(for clarification of official gene symbols). A ‘summary
of results’ table is shown indicating the number of genes
found for each dataset/tissue selected on the search
page. Below the summary of results are separate tables
and associated graphs for each dataset/tissue searched.
Each table contains the gene names searched, the official
gene symbol (or description) ,t h er e p r e s e n t a t i v ep r o b e
set, and the fold change with associated q value for each
stage of glaucoma, compared to the chosen reference
group. For ease of identification, significantly differen-
tially expressed values are shown in white on a red
background. Genes are ranked in the table based on the
chosen option in the detailed search tool (q value or
gene symbol). The graph provides a visual display of the
fold changes across all stages of disease for the genes of
interest, up to a maximum of ten. For searches contain-
ing more than 10 genes, the first 10 genes in the table
are displayed in the graph. Check boxes are available to
the left of each gene to allow the user to select up to 10
genes of choice to view in the graph. Results from the
table can be exported as comma separated values (csv,
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databases are also provided (see External resources
below).
Probe set details page (Figure 3c)
Each gene on the Affymetrix 430 v2 array is interro-
gated by a probe set of eleven 25 mer probes and a
gene can have multiple probe sets [21]. Each probe set
corresponds to a particular region of a gene and finding
that multiple probes sets for the same gene behave
similarly can add confidence to a result. Alternatively,
for those probe sets corresponding to alternatively
spliced exons/transcripts, multiple probe sets can give
insight into the behavior of splice variants [22]. Unfortu-
nately, some probe sets were designed to early versions
of gene sequences (prior to accurate genome sequence).
This results in some probes in a probe set not being
identical to the gene sequence. These probe sets will not
accurately reflect the level of transcript for these genes.
Figure 3 Schema and Main functions within GDP.( a) The home page contains direct links to users’ quick guide, the detailed search tool,
bulk downloads and a quick search that interrogates all datasets for a single gene of interest. The detailed search tool enables individual genes,
groups of genes or wild card searches (*). The bulk download option enables all differentially expressed genes for pairwise comparisons to be
retrieved. (b) The gene results page provides both a tabular and graphical view of the expression levels for the searched genes in the different
groups for each dataset selected. Access to gene information from external databases is provided (c) As multiple probe sets exist for many
genes on the Affymetrix 430v2 array, the probe set page details the results for each probe for a chosen gene(s). (d) The normalized expression
values for individual eyes in each group can be accessed.
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website where mapping information for each probe set
is provided. The values for the representative probe set
for each gene is displayed in the results summary page.
It is possible to view details for all probe sets for a given
gene, to view probe sets for selected genes or for all
genes in the table. The probe set detail page provides a
table/graph for each gene.
Expression values page (Figure 3d)
Values provided in the summary pages are relative fold
changes or log2 fold changes compared to a selected
reference. Each stage of disease contains biological repli-
cates, and the fold change for a given probe set (for a
given gene) is calculated as the average of the normal-
ized expression value of all replicates for a defined stage
of disease, relative to the reference group. The normal-
ized expression value reflects the relative abundance of
the gene in the tissue interrogated (either retina or optic
nerve head) with respect to all other genes. Those tran-
scripts with the highest normalized expression value are
most abundant. Conversely, those with the lowest nor-
malized expression value are less abundant. An expres-
sion level of approximately 4 or less may be considered
to represent a gene that is likely not expressed in the
assessed tissue (i.e. is close to background levels).
The relative abundance of transcripts corresponding
to particular probe sets is important information. For
instance, a small fold change in some lowly expressed
gene may have greater biological importance than a
small fold change in some abundant gene. Knowing the
variability in expression levels for different genes in indi-
vidual eyes within groups also is important. Within any
stage of disease (determined either morphologically or
molecularly), transcripts within individual biological
replicates may behave differently. Genes with low varia-
bility within groups may be better targets for interven-
tion strategies than variable genes. The expression
values corresponding to each probe set for individual
samples (replicates) can be accessed from the probe
details page. The expression levels are displayed as a his-
togram. The average (± 1 standard deviation) for the
reference group is indicated.
External Resources
Selected external resources can be accessed directly
from the results tables (Table 1). Resources were
selected to allow users the maximum access to current
information for genes of interest. The links to external
resources provided by Datgan can be easily adapted for
other user-specific databases. A major resource for
mouse-based expression is Mouse Genome Informatics
(MGI). This resource provides the research community
with information on the genetics, genomics and biology
of mice [17,23]. EntrezGene and OMIM are databases
that form part of the Entrez system at the National Cen-
ter for Biotechnology Information (NCBI) [18]. Entrez-
Gene provides gene-relevant information such as
transcript/protein sequences and links to relevant publi-
cations and genome browsers. OMIM provides a simpli-
fied disease-oriented description for a given gene
including mutations that have been shown to cause dis-
eases in humans. Finally, there are links to The Gene
Ontology (GO) database and the Kyoto Encyclopedia of
Genes and Genomes (KEGG), two databases that pro-
vide functional descriptions of genes. GO provides a
controlled vocabulary of terms for biological process,
cellular compartments and molecular function and is
accessed through MGI [17]. KEGG uses known func-
tional information to construct biologically relevant
pathways [19]. Given the uniformity of gene symbols
between the external resources and GDP it is possible
to identify groups of genes of interest (such as genes in
a given KEGG pathway or genes with the same GO
term) in the appropriate database and paste these genes
into the search tool in GDP.
Utility
In this section, we describe the workflow for extracting
the data relevant to members of the TNF superfamily.
This serves both to reinforce key features of the data-
base described above and as an example that could be
followed to interrogate any gene (or group of genes) of
interest.
Figure 4 A detailed search for members of the tumor necrosis
factor (TNF) superfamily. From the search tools box on the home
page, ‘tnf*’ was entered into the ‘Wild card Gene Symbol’ search
box. The search is not case sensitive. Both the ‘molecular ONH’
dataset (tissue ‘ONH’) and molecular retina (tissue ‘retina’) were
selected. No limits were set for fold change or q value and the
results are to be returned as fold change (FC).
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superfamily
TNF (formerly TNFa) has been suggested to be impor-
tant in retinal ganglion cell loss during glaucoma
[24,25]. Therefore, we assessed all members of the TNF
superfamily in both the molecular ONH dataset (Figure
2B, most sensitive dataset of early disease changes in the
optic nerve head), and the molecular retina dataset (Fig-
ure 2C, most sensitive dataset of early disease changes
in the retina).
Step 1: Performing detailed search (Figure 4)
First, we determined the best search option. In this case,
a wild card search using ‘TNF*’ will retrieve all TNF
superfamily members as no ap r i o r iknowledge about
which genes are present in the TNF superfamily is
required. Second, we selected the datasets and tissues of
interest - molecular ONH dataset, tissue ‘ONH’ and
molecular retina dataset, tissue ‘retina’. Finally, we
selected the reference group; in this case, D2-Gpnmb
+
control eyes. In this example, we did not limit our
search based on fold change or q value, and chose the
default options for the layout of the results page (display
expression differences as fold change rather than log2 of
fold change, and ordered genes based on significance of
gene expression differences (q value) rather than gene
symbol).
Step 2: Visualizing the results (Figure 5)
The results were returned below the original search box,
allowing straightforward modification of search options
if necessary. First, the summary table indicates that 50
genes met the criteria of the search for both the mole-
cular ONH and molecular retina datasets (Figure 5A).
These 50 genes have ‘TNF’ in either their official gene
symbol or in any MGI-approved alias(es). Below the
summary of results table, detailed results for each data-
set are displayed. In this example, we assess the results
for the molecular ONH dataset, tissue ONH. First, the
top 10 most significant genes are visualized in the graph
(Figure 5B). The results for all 50 genes are shown in
the table, the top 10 most significant of which are
s h o w ni nF i g u r e5 C .O ft h e5 0g e n e s ,3 4a r ed i f f e r e n -
tially expressed in at least one stage in the molecular
ONH dataset. To download all expression data in the
table, use the ‘Download as comma separated values
(CSV)’ option below the table. Expression values (and
associated q values) for the 50 genes across all stages of
disease are exported in excel-friendly format (Table 2).
Step 3: Interpreting the results (Figure 6)
Tnf shows only a modest increase in expression in stage
4 (1.2 fold, q value = 0.0413) in the molecular ONH
dataset. The five most significant genes are Tnf, alpha-
induced protein 8-like 2 (Tnfaip8l2), Tnf superfamily
receptor 1a (Tnfrsf1a,f o r m e r l yTnfr1) and 1b (Tnfrsf1b,
formerly Tnfr2), Tnf alpha-induced protein 2 (Tnfaip2)
and Tnf superfamily member 9 (Tnfrsf9)( F i g u r e5 C ,
Table 2). Tnfrsf9 has the highest fold change of all TNF-
related genes in the molecular ONH dataset, with a 2.9
fold expression difference compared to D2-Gpnmb
+
controls in stage 3. Of direct relevance to DBA/2J glau-
coma, Tnfrsf9 is involved in the proliferation of mono-
cytes that are precursors of microglia and macrophages
[26-28]. This information was retrieved from either
OMIM or Entrez Gene. Microglia/macrophages have
been shown to increase in the optic nerve head and
retina early in glaucoma [3,29].
As described above, many genes are represented by
multiple probe sets on the Affymetrix 430 v2 array.
Tnfrsf9 is represented on the array by three probe sets
(1460469_at, 1428034_a_at and 1421481_at) with
‘1460469_at’ being shown in the results table as the
most significant probe set of the three. Given the impor-
tance of all probe sets, full information can be accessed
through the probe set details page (Figure 3C and 6).
Only 1460469_at is differentially expressed in the mole-
cular ONH dataset, tissue ONH, the other two probe
sets show no significant difference compared to the D2-
Gpnmb
+ control group (Figure 6A). To view the nor-
malized expression levels of the probe sets in the optic
nerve head it is necessary to access the expression
values page (Figure 6B). The normalized raw intensity
Table 1 Summary of external resources accessed directly from GDP
Database Acronym Brief description Home page address
Mouse Genome Informatics MGI Gene catalogues, links to additional resources including phenotype
data, genome browsers and SNP databases
http://www.informatics.jax.org/
EntrezGene@NCBI EntrezGene Gene catalogues, links to additional resources including genome
browsers and SNP databases
http://www.ncbi.nlm.nih.gov/sites/
entrez?db=gene
Online Medelian
Inheritance in Man
OMIM Disease-oriented information http://www.ncbi.nlm.nih.gov/
omim/
The Gene Ontology@MGI GO Controlled vocabulary for functional attributes http://www.informatics.jax.org/
searches/GO_form.shtml
Kyoto Encyclopedia of
Genes and Genomes
KEGG Biological pathways http://www.genome.jp/kegg/
Ensembl Genome Browser Ensembl Determine alignment of probe sets onto genome sequence http://www.ensembl.org
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Page 8 of 13Figure 5 Results of the wild card search TNF*. (a) The summary of the results indicates the number of genes identified in each of the tissues
and datasets searched. (b-c) Result details are returned in graphical (b) and tabular format (c). For the molecular ONH dataset, the relative fold
change (with respect to the chosen reference) and the q value for the representative probe set for each gene is provided. The representative
probe set for each gene is determined as the probe set with the lowest average q value across all groups. The ten most significant differentially
expressed genes in the TNF superfamily are shown. Links are provided for each gene to selected external resources. These are MGI - by clicking
on the gene symbol (black arrow), Ensembl (by clicking the representative probe ID, blue arrow) EntrezGene, OMIM, GO and KEGG (database
(DB) links, far left). Details of all probe sets for a given gene can be accessed (green arrow).
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Page 9 of 13Table 2 All ‘Tnf’-related genes in the molecular optic nerve head dataset
Searched Symbol Representative
Probe Set ID
Num
Probe
Sets
FC for
Stage
1
QV for
Stage 1
FC for
Stage
2
QV for
Stage 2
FC for
Stage
3
QV for
Stage 3
FC for
Stage
4
QV for
Stage 4
FC for
Stage
5
QV for
Stage 5
Tnfaip8l2 Tnfaip8l2 1452948_at 1 1.595 0.0182 2.084 0.0008 2.093 0.0002 2.113 0.002 1.75 0.0033
TNFR60 Tnfrsf1a 1417291_at 1 1.356 0.0512 1.731 0.0008 1.86 0.0002 1.897 0.0006 1.688 0.0018
tnfb94 Tnfaip2 1438855_x_at 3 1.716 0.0183 2.109 0.0002 1.823 0.0021 1.539 0.0237 1.653 0.0126
Tnfrsf9 Tnfrsf9 1460469_at 3 1.512 0.0677 1.73 0.0002 2.921 0.0003 2.816 0.0005 1.807 0.005
TNF-
alphaR2
Tnfrsf1b 1418099_at 2 1.721 0.0831 2.098 0.0012 1.656 0.0078 2.381 0.002 2.264 0.0018
TNFCR Ltbr 1416435_at 1 1.269 0.1862 1.667 0.0001 1.6 0.0015 1.564 0.0002 1.316 0.0081
Tnfrsf11b Tnfrsf11b 1449033_at 2 1.872 0.1393 1.93 0.0106 1.614 0.0357 2.285 0.0099 2.354 0.0033
Tnfaip8 Tnfaip8 1416950_at 1 1.376 0.1972 1.548 0.0037 1.292 0.0629 1.701 0.0074 1.589 0.0085
Tnfsf13b Tnfsf13b 1460255_at 3 1.399 0.2727 1.622 0.0009 1.776 0.0044 1.652 0.0088 1.826 0.0024
Tnfaip6 Tnfaip6 1418424_at 1 1.66 0.2211 1.643 0.0739 2.088 0.0086 4.611 0.0003 2.737 0.0031
Tnfrsf13b Tnfrsf13b 1423182_at 1 1.284 0.272 1.79 0.0003 1.34 0.0408 2.029 0.0007 1.679 0.0066
Tnfip1 Tnfaip1 1448863_a_at 3 1.113 0.3315 1.295 0.0027 1.297 0.0015 1.469 0.0006 1.263 0.0025
Tnfrsf22 Tnfrsf22 1426095_a_at 4 1.331 0.3691 1.681 0.0098 1.672 0.0141 1.95 0.0048 1.537 0.009
Tnfrsf6 Fas 1460251_at 5 1.228 0.4172 1.545 0.0041 1.831 0.0038 1.755 0.0048 1.982 0.0025
Tnfrsf21 Tnfrsf21 1450731_s_at 2 1.166 0.3452 1.251 0.0098 1.363 0.0039 1.275 0.0225 1.218 0.0779
Tnfrsf12a Tnfrsf12a 1418571_at 2 1.301 0.3733 1.497 0.0759 2.851 0.0003 3.947 0.0002 1.941 0.0102
Tnfaip9 Steap4 1460197_a_at 2 1.177 0.5803 1.734 0.0044 1.576 0.0295 1.563 0.0477 1.832 0.0061
Tnfrsf5 Cd40 1439221_s_at 3 1.144 0.4776 1.238 0.0049 1.438 0.0067 1.72 0.0057 1.122 0.183
Tnfrsf10b Tnfrsf10b 1421296_at 2 1.335 0.3902 1.694 0.0074 1.609 0.0227 1.651 0.0194 1.099 0.3627
Tnfsf13 Tnfsf13 1418345_at 1 1.077 0.721 1.357 0.0094 1.328 0.0281 1.303 0.0875 1.431 0.0147
Tnfip3 Tnfaip3 1433699_at 2 -1.182 0.5997 -1.476 0.0076 -1.295 0.1286 -1.459 0.0288 -1.187 0.1717
Tnfrsf11a Tnfrsf11a 1430259_at 2 1.105 0.5704 1.279 0.022 1.092 0.2354 1.252 0.1037 1.207 0.1559
Tnfa Tnf 1419607_at 1 1.068 0.6746 1.164 0.1341 1.173 0.2162 1.197 0.0413 1.157 0.088
Tnfsf10 Tnfsf10 1459913_at 3 1.231 0.432 1.399 0.014 1.102 0.4007 1.134 0.3464 1.809 0.0027
Tnfrsf19 Tnfrsf19 1448147_at 3 1.281 0.2536 1.536 0.0052 1.023 0.5083 1.176 0.3387 1.208 0.0931
Tnfrsf13c Tnfrsf13c 1419307_at 1 1.084 0.7361 1.172 0.2768 -1.554 0.0445 -1.61 0.0562 -1.395 0.0958
Tnfrsf18 Tnfrsf18 1422303_a_at 1 1.113 0.5149 1.268 0.053 1.24 0.0632 1.114 0.2903 1.072 0.2896
Tnfsf3l Pglyrp1 1449184_at 1 -1.022 0.7984 1.241 0.1306 1.401 0.0694 1.273 0.1955 -1.363 0.099
TNF-beta Lta 1420353_at 1 1.165 0.3119 1.054 0.3871 1.059 0.3635 1.118 0.2847 1.194 0.0614
Tnfrsf14 Tnfrsf14 1452425_at 1 1.034 0.7298 1.181 0.0819 1.08 0.2514 1.075 0.3767 1.196 0.0106
Tnfsf14 Tnfsf14 1450298_at 2 1.11 0.4399 1.213 0.0478 1.05 0.4048 1.192 0.161 1.037 0.4038
Tnfsf8 Tnfsf8 1450272_at 2 1.049 0.682 1.146 0.1413 1.105 0.2307 1.128 0.1819 1.076 0.3008
Tnfsf7 Cd70 1449926_at 1 1.075 0.6845 1.202 0.1024 1.09 0.3569 1.54 0.023 -1.028 0.439
Tnfsf11 Tnfsf11 1419083_at 2 1.121 0.65 1.3 0.1171 1.144 0.2947 1.013 0.5497 1.517 0.0236
Tnfrsf16 Ngfr 1454903_at 3 -1.085 0.6105 1.019 0.5138 1.023 0.5083 -1.606 0.0053 -1.449 0.0062
Tnfsf6 Fasl 1449235_at 2 1.037 0.7033 1.133 0.1216 1.115 0.2646 1.016 0.5184 1.253 0.05
Tnfrsf7 Cd27 1452389_at 1 1.05 0.6727 1.168 0.1289 1.177 0.165 1.098 0.2723 -1.001 0.4951
Tnfrsf25 Tnfrsf25 1422231_a_at 1 1.081 0.5818 1.112 0.2304 1.071 0.3705 1.086 0.353 -1.03 0.434
Tnfsf4 Tnfsf4 1421744_at 1 1.014 0.7928 1.112 0.2484 1.055 0.3972 1.045 0.4892 1.284 0.0442
Tnfsf5 Cd40lg 1422283_at 1 -1.032 0.7476 -1.093 0.1604 -1 0.546 -1.014 0.5263 1.187 0.0304
Tnfsf9 Tnfsf9 1422924_at 1 1.036 0.7722 1.119 0.3593 1.145 0.3207 -1.027 0.5346 1.363 0.0246
Tnfrsf23 Tnfrsf23 1422101_at 1 -1.003 0.814 1.024 0.5169 1.035 0.4692 1.268 0.1378 1.215 0.109
Tnfaip8l1 Tnfaip8l1 1449125_at 1 1.039 0.7492 1.073 0.3754 1.114 0.231 1.118 0.3217 1.039 0.3833
Tnfsf3 Ltb 1419135_at 1 -1.076 0.7049 1.057 0.3884 1.026 0.4906 1.142 0.2959 -1.122 0.2268
Tnfrsf19l Relt 1455116_at 1 -1.055 0.7184 -1.009 0.5445 -1.151 0.1717 -1.124 0.3145 -1.043 0.4081
Tnfsf12 Tnfsf12 1452440_at 1 1.03 0.7513 -1.05 0.4461 1.066 0.3841 1.094 0.3333 1.107 0.2445
Tnfsf5ip1 Psmg2 1425373_a_at 2 -1.067 0.6716 -1.082 0.3645 1.119 0.1569 1.013 0.5411 -1.017 0.4574
Tnfrsf13 Tnfrsf17 1420782_at 1 -1.072 0.6676 -1.051 0.4316 -1.087 0.37 -1.033 0.5123 1.062 0.3875
Tnfrsf4 Tnfrsf4 1420351_at 1 -1.041 0.7555 -1.019 0.5272 1.047 0.4614 1.022 0.5351 1.031 0.4478
Tnfrsf8 Tnfrsf8 1421649_at 1 -1.002 0.8147 -1.005 0.5523 -1.028 0.4824 -1.001 0.5686 -1.051 0.3787
FC = Fold change, QV = Q value
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Page 10 of 13Figure 6 Analyzing multiple probe sets for Tnfrsf9 suggests that only the major transcript is expressed in the optic nerve head. (a)
The table from the probe set details page for the Tnfrsf9 gene (a graphical view is also available - not shown). Three probe sets are available for
this gene. Only one probe set, 1460469_at, is differentially expressed in the optic nerve head. The remaining two probes show no difference
with respect to D2-Gpnmb
+ control group. (b) The normalized expression values (intensity values) for the 1460469_at probe set for the
molecular ONH stages. This graph shows the variability of Tnfrsf9 expression in individual eyes. The normalized raw intensity values range from
between 4 and 7. The average of the reference group is shown (purple line) along with one standard deviation above and below the average
(grayed area). (c) Detailed mapping data for all probes within a probe set can be accessed in Ensembl by clicking on the probe set name in the
results table (black arrow, a). For each probe set, the genomic location of each of the eleven 25 mer probes that make up a probe set and any
mismatches are reported. For 146049_at, all probes match genomic intervals within the Tnfrsf9 gene. This is not the case for 1421481_at or
1428034_a_at (data not shown).
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Page 11 of 13values for individual eyes for the DE probe set
1460469_at range between 4 (considered background)
and 7. The raw normalized values for the other non-DE
probe sets do not increase significantly above
background.
The differing expression levels for the three Tnfrsf9
probe sets may result from detection of alternative splice
forms by the different probe sets or from errors in the
original probe set designs. The apparent differences in
expression levels between Tnfrsf9 probe sets are likely
due to probe sequence errors. Detailed data for all
probes within each probe set is available in Ensembl
and can be accessed directly from GDP. Only for probe
set 1460469_at do all eleven probes match identically
within the Tnfrsf9 gene (Figure 6c). Ensembl does not
report an alignment for any probes in the 1421481_at
probe set. For the remaining probe set, 1428034_a_at,
three of the eleven probes have mismatches, and
another three probes include intronic sequences that
would not be included in the messenger RNA. This
explains a lack of expression for this probe set as an
average of the expression level of all probes is taken.
Given this detailed probe information, it is clear that the
expression level of Tnfrsf9 is only truly represented by
the 1460469_at probe set.
In summary, using GDP, we have readily performed a
detailed search of all TNF superfamily members and
readily identified all genes that change significantly com-
pared to controls in two out of three different datasets.
In particular, the expression of Tnfrsf9 increases in the
optic nerve head at very early stages of glaucoma and
may be related to an accumulation of microglia. These
results are of great interest to the glaucoma community
and are immediately and freely available. They highlight
major advantages of accessing these gene expression
datasets through GDP, and the utility of Datgan for pro-
viding similar environments for many other datasets.
Discussion
Here, we describe GDP, constructed using the reusable
software system Datgan, for visualizing and interrogating
complex gene expression profiling data. Datgan is freely
available for download (via http://www.simonjohnlab.
org) and can be used to construct platforms for viewing
and interrogating any set of microarray or RNA-seq
based transcription profiling datasets. Datgan will be
particularly useful for complex diseases that have vari-
able onset and progression. As exemplified by GDP,
platforms developed using Datgan allow general access
and improved understanding of complex datasets.
Use of GDP is proving very important for understand-
ing our glaucoma datasets. For publication in most jour-
nals, all profiling datasets are required to be deposited
in either GEO (NCBI) or ArrayExpress (EBI). All data
and associated files for our study were deposited in
NCBI GEO (Accession number GSE26299). Data
deposition in these archives is necessary to ensure
access to all the raw data for interested parties. How-
ever, these archives were not designed to allow detailed
interrogation of multiple genes or biological pathways
across multiple datasets. GDP includes this functionality
and massively facilitates interrogation of our glaucoma
datasets by us, and the scientific community, ultimately
allowing the most benefit to be derived from the data.
Other gene expression profiling studies relevant to glau-
coma, which have been or will be carried out, also could
be incorporated into GDP. Many investigators, irrespec-
tive of computational expertise, can perform detailed ‘on
the fly’ searches quickly and easily.
Datgan is specifically designed to allow additional
datasets to be easily incorporated after the initial online
environment has been constructed. For glaucoma, other
gene expression profiling studies have been carried out
that could be included into GDP. These include studies
that have profiled additional animal models of glaucoma
[30-32]. In addition, comparing cell- and tissue- specific
transcription profiling studies (e.g [33]) in non-diseased
settings would enable hypotheses to be made about
which cells are changing early in glaucoma. Finally, use-
ful predictions could be made by comparing studies that
have profiled other relevant diseases such as other neu-
rodegenerative disorders or diseases affecting retinal
ganglion cells.
Conclusion
Datgan is a powerful software package for developing
user-friendly platforms to visualize transcription profil-
ing data. Implemented as GDP, it is already proving an
essential tool for interrogating the molecular pathogen-
esis of glaucoma.
Availability and Requirements
The database can be accessed via http://glaucomadb.jax.
org/glaucoma. Web browsers: Tested on the major web
browsers including the latest versions of Firefox, Safari
and Chrome. It has also been tested on smart phones and
tablet computers. Operating system(s): Tested on SUSE
Linux Enterprise Server 11 & OpenSUSE 11.0, and should
work on other versions of Linux and Mac OSX. Tools
required to establish Datgan-derived databases include:
Ruby 1.8.7, Rails 2.3.5, Python 2.6, Percona-Server-5.5.13
(should work with most MySQL), apache2, Mongrel Web
Server 1.1.5. Source code details can be obtained from the
Datgan tab at the top of the home page.
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